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Abstract. 
 
Decorin is a member of the expanding group 
of widely distributed small leucine-rich proteoglycans 
that are expected to play important functions in tissue 
assembly. We report that mice harboring a targeted dis-
ruption of the decorin gene are viable but have fragile 
skin with markedly reduced tensile strength. Ultra-
structural analysis revealed abnormal collagen mor-
phology in skin and tendon, with coarser and irregular 
fiber outlines. Quantitative scanning transmission EM 
of individual collagen fibrils showed abrupt increases 
and decreases in mass along their axes, thereby ac-
counting for the irregular outlines and size variability 
observed in cross-sections. The data indicate uncon-
trolled lateral fusion of collagen fibrils in the decorin-
deficient mice and provide an explanation for the re-
duced tensile strength of the skin. These findings 
demonstrate a fundamental role for decorin in regulat-
ing collagen fiber formation in vivo.
 
S
 
mall
 
 leucine-rich proteoglycans (SLRPs)
 
1
 
 belong to
an expanding family of secreted proteoglycans that
comprise structurally related but genetically distinct
products, including decorin, biglycan, fibromodulin, lumi-
can, epiphycan, and keratocan (28). The SLRPs share a
common structural architecture that can be divided into
three domains. The amino-terminal domain contains the
negatively charged glycosaminoglycan chains, dermatan or
chondroitin sulfate, or tyrosine sulfate. This region of the
molecule, which contains four conserved cysteine residues,
might be involved in binding to cationic domains of cell
surfaces and extracellular matrix proteins. The cysteine-
free central domain comprises 
 
z
 
80% of the protein and is
composed of eight to ten tandem repeats of leucine-rich
regions. This region is perhaps the best studied insofar as it
has been recently shown that specific amino acid se-
quences located between repeats 4 and 6 are responsible
for binding to type I collagen (51, 59). If the SLRPs fold in
a manner similar to the leucine-rich ribonuclease inhibitor,
the concave face of the molecule could interact with other
proteins as the ribonuclease inhibitor does with its sub-
strate (33). The carboxyl end domain contains two cysteine
residues, and its function still remains to be elucidated.
The evidence favoring protein–protein interaction as
the major function of SLRPs is persuasive. For example,
decorin binds noncovalently to the surface of fibrillar col-
lagen, primarily type I (53), and retards the rate and de-
gree of collagen fibrillogenesis in vitro (66). This specific
interaction is mediated by the protein core (42), whereas
the glycosaminoglycan chain of decorin extends laterally
from adjacent collagen fibrils, thereby maintaining inter-
fibrillar spacing (52). This lateral orientation has also been
demonstrated in collagen fibrils reconstituted in vitro in
the presence of decorin (55). Thus, coordinated expression
of decorin and associated collagens may regulate an or-
derly matrix assembly.
Decorin purportedly binds to collagen types II (66), III
(60), and VI (6), fibronectin (48), C1q (34), and transform-
ing growth factor-
 
b
 
 (20). Moreover, decorin has been im-
plicated in the control of cell proliferation by inducing ar-
rest of tumor cells in the G
 
1
 
 phase of the cell cycle (14, 47).
To gain further insights into the functional role of deco-
rin and to explore tissue specificity and functional redun-
dancy during development, we generated mice disrupted
at the decorin gene locus. The nullizygous animals were vi-
able but showed skin fragility with marked reduction in
tensile strength. Compared with normal skin, the collagen
fiber network was more loosely packed with abnormal col-
lagen fibers varying in diameter along their shafts. These
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observations provide the first genetic evidence that deco-
rin is essential for proper collagen fibrillogenesis and dem-
onstrate an important role for this proteoglycan in a pro-
cess fundamental to animal development. Our results also
provide insights into how disruption of collagen fibrillo-
genesis might result in pathology and predict the potential
existence of a human genetic disease caused by mutations
in the decorin gene locus.
 
Materials and Methods
 
Targeting Vector and Identification of Targeting Events
 
A 5.5 XbaI decorin genomic fragment isolated from a 
 
l
 
FIX II genomic
mouse 129Sv library (49), isogenic to the embryonic stem (ES) cells, was
used to construct the decorin targeting vector. This genomic fragment, en-
compassing exons 1 and 2, was ligated into pBluescript KS with a deleted
EcoRV site, and the resulting fragment was designated pMD. A plasmid
containing Pgk-neo (58) was digested with XhoI and EcoRV, and the
XhoI site was made blunt-ended with Klenow polymerase. The resulting
Pgk-neo fragment of 1.6 kb was ligated into a unique EcoRV site of exon
2, thereby dividing the genomic fragment into two arms of homology of
 
z
 
3.8 and 
 
z
 
1.7 kb to the targeted locus, respectively. To enrich for target-
ing events, the diphtheria toxin-A cassette driven by the thymidine kinase
promoter (70) was added downstream of the targeting vector into the
XhoI site of the multiple cloning site of pMD. Linearization of this target-
ing vector was done with NotI before electroporation into the ES cells.
The R1-ES cells (39) were cultured in standard ES cell culture conditions
(2), in DME supplemented with 15% FCS, 0.1 mM 
 
b
 
-mercaptoethanol,
and 1,000 U/ml of human lymphocyte inhibitory factor (h-LIF) on neomy-
cin-resistant primary cultures of embryonic fibroblast feeders. LIF was
produced from the CHO cell line stably transfected with the h-LIF cDNA.
Cells were electroporated with 40 
 
m
 
g/ml of decorin targeting vector. The
resulting G418-resistant clones were isolated by ring-cloning and ex-
panded (3). Approximately 100 clones were analyzed by Southern blot
analysis for the detection of the correct targeting events (see below).
 
Germ-Line Transmission, Husbandry,
and Genotype Determination
 
Targeted ES cells were introduced into mouse blastocysts according to
standard procedures. The resulting chimeras were bred to B1/Swiss fe-
males. Tail DNA from B1/Swiss female agouti progeny was tested for the
presence of the targeted allele by Southern blot analysis. Heterozygous
mice from 129Sv X B1/Swiss mixed background were mated to homozy-
gosity. The genotype of each mouse was determined by Southern blotting
and/or PCR analysis of mouse tail DNA. Genomic DNA from mouse tail
fragments was digested with EcoRI and separated on 0.8% agarose gels.
A 310-bp probe encompassing a sequence just 5
 
9
 
 to the targeting vector
was prepared by PCR using the T7 primer from a subcloned 5.5-kb ge-
nomic fragment of mouse decorin phage clone F 11-1 (49) and an anti-
sense primer specific to exon 1. This probe detects a 7- or 6.5-kb sequence
of DNA digested with EcoRI derived from normal wild-type and targeted
animals, respectively. Alternatively, PCR was used to detect the presence
of homologous recombination of the decorin gene. Sense and antisense
primers corresponding to exon 2 of murine decorin (5
 
9
 
-CCTTCTGGCA-
CAAGTCTCTTGG-3
 
9
 
 and 5
 
9
 
-TCGAAGATGACACTGGCATCGG-3
 
9
 
)
were used to detect a 161-bp fragment, indicating lack of homologous re-
combination. An additional primer corresponding to the Pgk promoter of
the Pgk-neo cassette (5
 
9
 
-TGGATGTGGAATGTGTGCGAG-3
 
9
 
) was
used to detect a 250-bp fragment, indicating the presence of homologous
recombination. The reaction mix of 28 
 
m
 
l consisted of 100–500 ng genomic
DNA, 100 ng each of the three primers, 1.8 mM MgCl
 
2
 
, 1
 
3
 
 buffer, 360 
 
m
 
m
dinucleotide triphosphates, and 2.5 U of Taq polymerase. Reaction condi-
tions were: 1 min at 95
 
8
 
C, 20 s at 57
 
8
 
C, and 30 s at 72
 
8
 
C for 35 cycles.
 
Hematological Analysis, RNA Extraction, Proteoglycan 
Purification, and Immunoblotting
 
Approximately 0.5 ml of blood was retrieved by cardiac puncture of ho-
mozygous animals and their respective control litter mates (
 
n
 
 
 
5
 
 6). A full
body profile, including hematological and clinical chemistry, was per-
formed as described before (4). Differential white blood cell counts were
determined manually on blood smears after Wright staining. RNA was
isolated from mouse tissues using a “Tri” reagent (Molecular Research
Center, Cincinnati, OH), and separated on agarose formaldehyde gels.
Proteoglycans were extracted from 
 
z
 
50 mg of adult mouse tail tissue in 4 M
guanidine HCl, 100 mM sodium acetate buffer, pH 6.0, containing the fol-
lowing protease inhibitors: 1 mM PMSF, 5 mM benzamidine HCl, 5 mM
iodoacetamide, 5 
 
m
 
g/ml leupeptin, 5 
 
m
 
g/ml pepstatin, and 10 mM EDTA.
After a 64-h extraction at 4
 
8
 
C with gentle rotation, the unextracted resi-
due was removed by centrifugation, while the supernatant was dialyzed
against 0.1 M NaCl, 0.1 M Tris HCl, pH 7.3, for 72 h at 4
 
8
 
C. An aliquot of
100 
 
m
 
l of the dialysate was incubated with protease-free chondroitinase
ABC (165 mU/ml) overnight at 37
 
8
 
C in the presence of chondroitin 4-S
and 6-S (0.1 
 
m
 
g/ml) as carrier. Total protein was precipitated with 10 vol of
cold 100% ethanol and collected by centrifugation. The resulting pellet
was air dried and resuspended in 40 
 
m
 
l SDS-PAGE buffer. Proteins were
separated on 8–10% polyacrylamide gels and transferred to nitrocellulose
(Hybond ECL; Amersham Corp., Arlington Heights, IL) for 1 h at 700 mA.
Immunoblots were incubated overnight at 4
 
8
 
C in a blocking solution con-
taining TBS-T (20 mM Tris-HCl, pH 7.6, 137 mM NaCl, 0.1% Tween 20)
and 5% nonfat dry milk. After washing the membrane with TBS-T, it was
incubated for 1 h in a 1:5,000 dilution of a rabbit anti–mouse decorin anti-
serum (LF-113), which was generated against a synthetic decorin peptide
from the amino-terminal region spanning residues 36–49 of the mouse
protein (16). The membrane was extensively washed with TBS-T, and then
incubated for 1 h with goat anti–rabbit IgG conjugated to HRP (Sigma
Chemical Co., St. Louis, MO) diluted to 1:10,000 in TBS-T. After further
washing, the antigen/antibody complexes were detected with ECL detec-
tion reagents (Amersham Corp.) according to the manufacturer’s instruc-
tions. Exposure of the immunoblot to XAR5 film (Eastman Kodak Co.,
Rochester, NY) was for 2–10 s.
 
Morphological and Immunohistochemical Studies
 
Tissues were fixed in 10% buffered formaldehyde and processed for light
microscopy (27). For immunohistochemistry, paraffin sections were
warmed to 50
 
8
 
C for 30 min, dewaxed in xylene, and rehydrated through
decreasing concentrations of ethanol. Endogenous peroxidase activity was
blocked by a 15-min preincubation with methanolic H
 
2
 
O
 
2
 
 (0.5% vol/vol).
After washing in TBS, pH 7.5, the sections were incubated with normal
goat serum (1:200) for 30 min, washed extensively with TBS, and incu-
bated with the rabbit polyclonal LF-113 anti-decorin or the LF-106 anti-
biglycan antisera (16) at 1:1,000 dilution for 18 h at 4
 
8
 
C. The LF-106 is di-
rected against a murine biglycan synthetic peptide, amino acids 50–64,
conjugated to horseshoe crab hemocyanin (16). An HRP-conjugated goat
anti–rabbit IgG (Sigma Chemical Co.) was applied at 1:200 dilution for 45
min. A 3-amino-ethyl carbazole substrate kit (AEC; Vector Laboratories
Inc., Burlingame, CA) was used to visualize the specific peroxidase activ-
ity. The sections were washed in water, counterstained with 0.2% methyl-
ene blue, and mounted with Gel/Mount aqueous medium (Biomeda Co.,
Foster City, CA) before photography. For EM, small portions of skin, tail
tendon, or cornea were fixed in 3% glutaraldehyde, 25 mM sodium ace-
tate buffer, pH 5.7, containing 0.3 M MgCl
 
2
 
 and 0.05% cuprolinic blue
(53). The unosmicated tissues were rinsed three times in buffer containing
MgCl
 
2
 
, en bloc stained with 1% sodium tungstate, dehydrated in graded
alcohols, and embedded in Spurr’s epoxy resin. Thin-sections were ob-
served with a transmission electron microscope 100B (JEOL USA, Pea-
body, MA), with or without further staining with uranyl acetate (27) or so-
dium tungstate (53). For quantitative studies, collagen fibril diameters
were measured on photographic prints with a calibrated final magnifica-
tion of 90,000. Several hundred micrographs were taken from the skin,
tendon, and cornea of five homozygous, two heterozygous and three wild-
type animals. A total of 2,803 collagen profiles from wild-type, heterozy-
gous, and homozygous skin was measured, and histograms were gener-
ated. For scanning transmission EM (STEM) analysis, 4-mm
 
2
 
 pieces of
skin were finely minced, suspended in 1 ml Tris-buffered (pH 7.4) saline
supplemented with 50 mM EDTA and 100 mM sucrose, and subjected to
mild disruption in a hand-held Dounce homogenizer. The supernatants
were then sampled for EM. Fibrils were adsorbed to 400-mesh carbon-
filmed grids, washed with ultrapure water, and air dried. The unstained
fibrils were examined by STEM and mass mapping procedures (21, 22, 23).
 
Biomechanical Test of Skin Tensile Strength
 
Dorsal skin was carefully excised and pinned out on a styrofoam support.
Using a plastic template, dumbbell-shaped skin specimens (4 cm 
 
3
 
 2 cm) 
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oriented parallel to the spine were dissected with the aid of a scalpel and
placed between two microscope slides. The specimens were kept moist
with cold saline and transported to the bioengineering laboratory on ice.
The overall thickness of the specimens was measured with a micrometer
while the skin was between glass slides and found not be significantly dif-
ferent among animals. A tensile machine displacement controller manu-
factured by Comten Industries Inc. (St. Petersburg, FL) was used to mea-
sure tensile strength of the skin specimens, which were gripped between
specially designed clamps equipped with Velcro-covered faces to prevent
slippage of the tissue. The skin specimens were kept continuously moist
with room temperature saline and stretched at a low speed rate of 1 mm/s
(10%/s) until failure. Tensile strength was computed from maximal load
or force in newton (N) at failure divided by the initial cross-sectional area
of the specimen in the reduced test area (32, 46).
 
Results
 
Generation of the Decorin Null Mice
 
The genomic locus encoding the murine decorin gene was
targeted with a replacement construct containing 
 
z
 
5.5 kb
of DNA sequence interrupted in exon 2 by the neomycin
resistance cassette driven by the Pgk promoter (Fig. 1 
 
A
 
).
We made use of a positive/negative selection scheme by
using neomycin resistance for positive selection and diph-
theria toxin-A driven by the thymidine kinase promoter
for negative selection of nonhomologous recombinants
Figure 1. Disruption of the
decorin gene locus in mouse
ES cells and generation of
decorin-deficient mice. (A)
Targeting strategy. A 5.5-kb
XbaI genomic fragment en-
coding exons 1 and 2 (filled
boxes, not in scale) was used
to construct the targeting
vector. The predicted struc-
ture of the disrupted allele
(bottom panel) shows the 59
probe used to detect the di-
agnostic allele of 6.5 kb in
contrast with the wild-type
allele of 7.0 kb. This was due
to the presence of a new
EcoRI site in the Pgk-neo
cassette. Abbreviations for
restriction endonucleases: E,
EcoRI; X, XbaI; N, NotI; Xh,
XhoI. (B) Southern blot
analysis of tail DNA isolated
from two separate litters of
mice including wild-type (1/
1), heterozygous (1/2),
and homozygous (2/2) ani-
mals. Lanes 1–3 are from
3-mo-old animals derived
from the breeding of two het-
erozygous mice, while lanes
4–9 are from newborn ani-
mals derived from the breed-
ing of a heterozygous male
and a homozygous female.
The targeted allele of 6.5 kb
is labeled by an asterisk. The
DNA was separated on a
0.75% agarose gel, trans-
ferred to a nitrocellulose fil-
ter, and hybridized under
high stringency to a PCR-
generated probe 59 to the
targeting vector. The size of
molecular weight markers is
indicated in the left margin in
kb. (C) PCR detection of the
targeted allele using primers specific for exon 2 (a and c, top scheme) or Pgk-neo (primer b). By using primer a and c, a fragment of 161
bp was identified in the wild-type (lane 1) and heterozygous animal (lane 2). However, the combination of primer b and c gave rise to a
larger fragment of 250 bp, encompassing the 39 end of the neo cassette and the 39 end of exon 2, which was detected only in the het-
erozygous (lane 2) and homozygous (lane 3) animals. The products were separated on a 6% nonreducing polyacrylamide gel and
stained with ethidium bromide. The size in bp is indicated in the left margin. 
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(70). 110 G418-resistant ES clones were isolated and ex-
panded. Homologous recombination was detected by South-
ern blotting with a single genomic probe flanking the con-
struct. This probe detected a 6.5-kb EcoRI fragment
specific for the targeting vector (the neo cassette has an in-
ternal EcoRI site), and a 7-kb EcoRI fragment specific for
the wild-type allele. Among the first 51 clones that were
screened by Southern blotting, 13 (
 
z
 
25% targeting fre-
quency) had the predicted 6.5-kb EcoRI band correspond-
ing to the targeted allele (not shown). Two independent
ES clones with a normal karyotype were used to produce
male chimeras that were able to affect germ-line transmis-
sion of the disrupted allele when bred to C57BL/6 females.
Crosses of heterozygous parents resulted in the birth of
mice that were homozygous for the mutant 
 
Dcn
 
 gene
based on either Southern blotting (Fig. 1 
 
B
 
) or PCR (Fig.
1 
 
C
 
) of tail biopsy DNA.
 
Homozygous Mutant Mice Are Viable
 
Mice heterozygous for the decorin knockout mutation
(129Sv X Bl/Swiss mixed background) were mated to ho-
mozygosity. The resulting progeny (
 
n
 
 
 
5
 
 69) showed a stan-
dard Mendelian transmission: 16 homozygotes (23%), 37
heterozygotes (54%), and 16 wild type (23%). This Men-
delian distribution was subsequently observed in several
progenies derived from mating heterozygous animals. To
confirm the disruption of both decorin alleles, the absence
of decorin-specific transcript was checked by Northern
blotting analysis. Total RNA from several major tissues,
including manubrium sterni (which contains cartilage,
bone, and bone marrow), heart, liver, kidney, and skin, an
organ that is known to express high levels of decorin mes-
sage (49), showed no detectable decorin-specific transcript
(Fig. 2 
 
A
 
). Thus, both copies of the decorin gene were suc-
cessfully disrupted by homologous recombination initiated
by our targeting vector. As expected, the levels of decorin
were slightly reduced in the 
 
Dcn
 
1
 
/
 
2
 
 animals when nor-
malized on the housekeeping gene 
 
GAPDH
 
. Moreover,
when the Northern blots were hybridized with either a
full-length cDNA probe encoding murine biglycan or a re-
verse transcriptase–PCR-generated probe encoding a por-
tion of murine lumican, no significant change in either
transcript was observed (not shown). These findings indi-
cate that neither biglycan nor lumican (murine fibromodu-
lin probe was not available) is upregulated to compensate
Figure 2. Absence of decorin
mRNA and protein in ani-
mals harboring a homozy-
gous disruption of the deco-
rin gene. (A) Northern blot
analysis using total RNA
prepared from selected tis-
sues as indicated of wild-type
(1/1), heterozygous (1/2),
and homozygous (2/2) adult
animals. High stringency hy-
bridization was performed
using cDNAs encoding the
full-length decorin or the
housekeeping gene GAPDH
as  32P-labeled probes (49).
Notice the lack of decorin transcripts in the Dcn2/2 animals (lanes 9–12, 15, and 16). (B) Immunoblot analysis of guanidine HCl ex-
tracts of tail tissues before or after chondroitinase ABC (1ABCase) digestion using an anti-decorin antibody. Notice the presence of a
proteoglycan centering around 94 kD and the presence of a 45-kD unprocessed protein core in the wild-type (lane 1) and heterozygous
animal (lane 2); no immunoreactive material was detected in the homozygous animal (lane 3). After chondroitinase ABC digestion, the
high molecular mass proteoglycan was converted into two broad bands of 45–50 kD (lanes 4 and 5). Decorin-specific epitopes were de-
tected with a polyclonal antibody (LF-113) directed against a synthetic decorin peptide from the amino-terminal region spanning resi-
dues 36–49 of the mouse protein (16).
Figure 3. The phenotype of decorin-deficient mice reveals thinning and fragility of the skin. (A) Gross photograph of wild-type (1/1),
heterozygous (1/2), and homozygous (2/2) littermates. Notice the sharp rupture of the back skin in the 2/2 animal (arrows) and the
detachment of the tail skin (arrowheads) that occurred during cervical dislocation. The skin fragility was never observed in either 1/1
or 1/2 animals (n . 300). B is a cross-section of the detached tail skin. Notice the sharp and bloodless line of rupture (arrowheads)
along the deeper dermis. Immunohistochemical analysis of skin and skeletal muscle (C and D), mammary gland (E), and uterus (F)
from wild-type (1/1) and decorin-deficient (2/2) animals using the LF-113 anti-decorin antibody. Notice the intense immunoreactivity
in the dermis of a wild-type animal (C, asterisks) and the fine immunoreactivity on either side of the skeletal muscle (Mu). In contrast,
the 2/2 dermis (D, asterisk), the subcutaneous and perimysial connective tissues, are totally unreactive as are the uterine wall and mu-
cosa (F). As expected, the anti-decorin antibody labeled specifically the adventitia of small blood vessels (E, arrowheads) and the myo-
epithelial cells and fine connective tissue surrounding mammary ducts (E, arrows). Immunodetection of biglycan using an anti-peptide
(LF-106) antibody in uterus (G) and skin (H) from Dcn2/2 mice. Notice the “normal” expression of biglycan in the endometrium (G,
arrows) and in the intramural small blood vessels (G, arrowheads). As expected, in skin, both the epidermis (H, arrowheads) and the fol-
licular epithelium (H, arrow) were labeled by the anti-biglycan antibodies. Sections were reacted with LF-113 or LF-106 antisera at 1:
1,000 dilution, and then visualized with peroxidase-conjugated IgG (1:200) followed by counterstaining with 0.2% methylene blue. Bar,
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for the lack of decorin in any of the tissues examined so
far. The results obtained at the mRNA levels were con-
firmed by the absence of the immunoreactive decorin pro-
teoglycan from whole tail extracts (Fig. 2 B). When par-
tially purified proteoglycans were separated by 7.5% SDS
gel electrophoresis and immunoblotted, no decorin immu-
noreactivity was observed by using a specific antipeptide
antibody (16) either before (Fig. 2 B, lane 3) or after (Fig.
2 B, lane 6) chondroitinase ABC treatment, in spite of the
fact that approximately equal amounts of protein were
loaded on the gel. Collectively, these results indicate that
disruption of both alleles of the mouse decorin gene re-
sults in abrogation of decorin message and protein.
Lack of Decorin Leads to Thinning and Fragility
of the Skin
Initial analysis of the Dcn2/2 mice did not reveal any
gross anatomical abnormalities. The animals grew to nor-
mal size, were fertile, and did not exhibit obvious behav-
ioral deficiencies. A complete serum chemistry and hema-
tological profile of 2-mo-old homozygous and control mice
did not show any significant difference in the levels of al-
bumin, globulin, electrolytes, sodium, and chloride, in the
hepatic enzymes, ALT and AST, or in the number of
white and red blood cells, hematocrit and hemoglobin. Ra-
diographical studies of whole animals did not reveal any
overt bone abnormalities in the decorin-deficient animals
(not shown). However, closer analysis of the Dcn2/2 mice
revealed skin laxity and significant fragility. When 3-mo-
old mice were sacrificed by cervical dislocation, the simple
application of pressure to the cervical region caused an
abrupt rupture of the skin (Fig. 3 A, arrows). In addition
the skin of the tail was detached in its entirety from the un-
derlying soft tissues (Fig. 3 A, arrowheads). Light micro-
scopic observation of the skin from the tail showed a sharp
detachment of the skin between the deeper dermis and the
fascia, with clean, sharp edges along the dissection (Fig. 3 B,
arrowheads). Random sampling of abdominal skin from
several Dcn2/2 mice revealed dermal thinning and loose
connective tissue in the hypodermal layer (Fig. 3 D). Thus,
skin laxity observed in the decorin-deficient animals could
be due at least in part to accumulation of loose connective
tissue in the dermal and hypodermal layers. In contrast,
age-matched Dcn1/1 mice littermates (Fig. 3 C) or Dcn1/2
animals (not shown) showed no such structural changes.
To confirm the absence of decorin, immunohistochemical
analysis using the anti-decorin antibody showed no detect-
able epitopes in the skin of Dcn2/2 animals (Fig. 3 D). In
addition, all the tissues tested, including skeletal muscle,
adipose tissue, and uterus (Fig. 3, D and F), as well as
Fallopian tubes and ovaries (not shown), revealed no deco-
rin immunoreactivity. In contrast, the wild-type animals
showed the expected immunoreactivity in the dermis (Fig.
3 C, asterisks), in the myoepithelial layer and connective
tissues surrounding mammary ducts (Fig. 3 E, arrows), and
in the adventitia of small blood vessels (Fig. 3 E, arrow-
heads). In the Dcn2/2 animals, staining with an antibody
against biglycan showed the presence of this epitope in the
endometrium and intramural blood vessels (Fig. 3 G), as
well as in the epidermal layer and follicular epithelium
(Fig. 3 H).
The rupture of the skin similar to that shown in Fig. 3 A
had a considerable penetrance, insofar as it was observ-
able in .50% of all the Dcn2/2 mice. In contrast, skin
fragility was never observed in the heterozygous, wild-type
animals; nor was it encountered in other animals (n . 300)
with similar genetic background but harboring a wild-type
allele. These data indicated that, to obtain the skin fragil-
ity phenotype, both decorin alleles had to be inactivated.
Skin of Decorin-deficient Animals Exhibits Reduced 
Tensile Strength
It is generally accepted that skin strength correlates di-
rectly with the overall organization, content, and physical
properties of the collagen fibril network (15). Therefore,
to achieve a more objective measurement of skin fragility,
we determined the tensile strength in the physiological
range of loading (low rate of loading) in portions of dorsal
skin from six animals, three wild-type and three Dcn2/2
mice. Two fresh specimens per animal of identical dumb-
bell-shape were generated on a plastic template, and load/
Figure 4. The skin of decorin-deficient mice has reduced tensile
strength. Freshly excised, dumbbell-shaped samples (4 3 2 cm) of
dorsal skin oriented parallel to spine from 1/1 (d) or 2/2 (s)
animals were generated on a plastic template, thereby producing
skin specimens with a narrow central region (1 cm2) where failure
would occur by avoiding stress concentration at the jaws of the
grip. The samples were gripped into a tensile testing machine
(model 4Z387A; Comten Industries) and stretched to tensile fail-
ure at a constant strain rate of 1 mm/s, equivalent to 10%/s. A
data collecting system linked to a Macintosh Quadra computer
(Apple Computer Inc., Cupertino, CA) was used to generate
load/displacement curves. Peak of curve represents point of fail-
ure. Tensile strength was computed from maximal load at failure
divided by the initial cross-sectional area of the specimen in the
reduced test area. Six age-matched animals were analyzed with
two specimens per animal. Data points represent a typical experi-
ment from one animal each.Danielson et al. Abnormal Collagen and Skin Fragility in Decorin Null Mice 735
displacement curves were determined by subjecting them
to a stress rate of 1 mm/s (10%/s) with constant recording
by a Comten tensile machine displacement controller. Ten-
sile strength was expressed as the maximal load or force in
newton (N) before skin failure divided by the initial cross-
sectional area (1 cm2) of the specimen in the central test
area (46). A typical experiment derived from stretching
fresh dorsal skin from two age-matched animals is shown
in Fig. 4. The skin from the decorin-deficient animals ex-
hibited a premature failure at z7 N, in contrast with the
skin from the wild type that ruptured at z27 N. The over-
all values of tensile strength measurements were signifi-
cantly reduced in Dcn2/2 animals (7 N 6 2) as compared
with the wild-type animals (21 N 6 5). The data further
suggest that the decorin-deficient mice exhibited a reduc-
tion in ductility, i.e., the percentage of deformation before
failure (calculated from the displacement values in Fig. 4).
The normal values centered around 170% vs 110% for the
decorin-deficient animals. These independent biomechan-
ical parameters thus confirm the observation of skin fragil-
ity reported above and indicate that the decorin-deficient
phenotype is due to a decline in the intrinsic tensile
strength of the skin.
A Structural Basis for Skin Fragility in the
Decorin-deficient Mice: Abnormal Morphology of 
Collagen Fibrils and Reduction of
Collagen-bound Proteoglycans
Ultrastructural analysis of dermal collagen from the skin
of 3-mo-old Dcn2/2 animals revealed aberrant organiza-
tion of collagen fibrils with several distinct structural ab-
normalities. First, dermal collagen was less orderly packed
(Fig. 5 A) than age-matched wild type (Fig. 5 C). Second,
there was great variability in shape and size (Fig. 5, A and
B); individual fibrils exhibited irregular outlines in cross-
section compared with the circular outline of controls. In
some instances, the cross-sectional profiles of collagen
fibrils in affected dermis reached very large diameters up
to 240–260 nm (Fig. 5 A, asterisks) and showed scalloped
edges (Fig. 5 A, arrowhead) or focal lateral fusion with
thinner fibrils (Fig. 5 B, arrowheads). In contrast, het-
erozygous (not shown) or wild-type skin (Fig. 5 C) showed
collagen fibrils with fairly uniform, circular cross-sectional
profiles. Third, there was the coexistence of thin collagen
fibrils (Fig. 5 A, circles) intermingled with large ones,
whereas in the wild type the average size was quite uni-
form. As a result of the overall round shape of the col-
lagen fibrils, it was possible to measure the average diame-
ter of several hundred cross-sectional profiles. The results
demonstrated that the average collagen diameter did not
significantly vary between wild-type (Fig. 5 D) and ho-
mozygous animals (Fig. 5 E), 116 6 18 (n 5 788) vs 119 6
35 (n 5 795), respectively. However, the Dcn2/2 animals
exhibited a wider range with profiles varying between 40
and 260 nm, confirming the qualitative data shown above.
In contrast, the wild-type animals contained profiles rang-
ing between 40 and 180 nm. The heterozygous animals had
a distribution and an average collagen diameter (118 6 14;
n 5 1,220) nearly identical to the wild type (not shown).
Ultrastructural analysis of tail tendon collagen revealed
even more bizarre profiles and shapes. Individual fibrils
exhibited very irregular, ragged outlines in cross-section
compared with normal skin. The collagen fibrils reached
660 nm in diameter (Fig. 6, A and B) in contrast with the
wild-type animals where the average was about 200 nm
(Fig. 6 C). The aberrant fibrils appeared to be due to mul-
tiple and concurrent lateral fusions of their central thick
segments to thinner fibrils (Fig. 6 B). Moreover, intermin-
gled with these gigantic fibrils were numerous thin fibrils
with an average diameter of 40–60 nm. These thin fibrils
were less frequently detected in tendons of age-matched
controls. Since decorin is also expressed in the cornea, we
analyzed the ultrastructure of the corneal collagen in wild-
type, heterozygous, and homozygous animals. We found
no significant changes in either packing or overage size of
corneal collagen in the Dcn2/2 animals (not shown).
To investigate further the role of proteoglycans in col-
lagen fibrillogenesis, we processed skin and tendon in the
presence of cuprolinic blue, a cationic dye that preserves
proteoglycans in an extended configuration in the pres-
ence of 0.3 M MgCl2 (53). Under such high salt concentra-
tion, binding of the dye is specific for proteoglycans with
sulfate esters. Using this method, decorin has been local-
ized to the d and e bands in the D-gap zone of collagen
quarter-stagger in tendon, cornea, and pericardium (52,
53, 56), a localization confirmed by immunoelectron mi-
croscopy (43, 56) and in situ staining of isolated molecules
(35). When collagen fibrils from tail tendons were fixed in
the presence of cuprolinic blue and stained with uranyl ac-
etate to visualize the banding pattern, it was evident that
the collagen of affected animals (Fig. 6 E) exhibited the
67-nm periodicity characteristic of type I collagen. As ex-
pected, in the Dcn1/1 animals, all the d bands were occu-
pied (Fig. 6 D, rows of arrowheads). In contrast, in the
Dcn2/2 animals, several d bands contained no orthogo-
nally arrayed proteoglycan granules (Fig. 6 E, spaces be-
tween arrowheads and also unfilled arrows). Moreover, we
found a significant reduction of proteoglycan granules and
filaments around dermal collagen fibrils of homozygous
animals when compared with wild type (not shown). The
proteoglycans appeared smaller in average length in the
Dcn2/2, likely reflecting the presence of keratan-sulfate–
containing proteoglycans, such as fibromodulin and lumi-
can, that are known to be expressed in both tendon and
skin (28). Collectively, these results provide a structural
basis for the phenotype described above and further indi-
cate that the abnormal collagen morphology is associated
with a decrease in collagen-bound proteoglycans. The loss
of such important protein/protein interaction sites could
significantly contribute to the abnormal collagen fibrillo-
genesis described above.
Mass Mapping of Dermal Fibrils from
Decorin-deficient Animals Reveals Pronounced 
Nonuniformity in the Axial Mass Distribution
Next, we wished to determine whether the collagen fibrils
from the skin of Dcn2/2 animals were uniform along
their axes. This was investigated by determining the axial
mass distributions of unstained, isolated fibrils using STEM.
Dispersed fibrils of up to z55 mm (z800 D-periods; 1 D 5
67 nm) in length were prepared, and montages of STEM
images were recorded along the entire lengths of eachThe Journal of Cell Biology, Volume 136, 1997 736
fibril. Consecutive mass per unit length measurements (av-
erages over two D-periods) were made along each fibril.
Typical results are shown in Fig. 7. Fibrils from Dcn2/2
animals showed pronounced nonuniformity along their axes
compared with the Dcn1/1 control fibrils. A typical un-
stained fibril from the homozygous animals showed re-
peated bulges along the axis (Fig. 7 A). Axial mass distri-
butions of these fibrils revealed a series of mass peaks,
often with a factor of two or three times the mass per unit
length of the adjacent parts of the fibril, and each typically
extending 50–80 D-periods along the fibril (Fig. 7, D–F).
In contrast, fibrils from the wild-type animals appeared
uniform in STEM images (Fig. 7 C), and axial mass mea-
surements confirmed that these fibrils lacked the mass
peaks seen regularly in the homozygous animals (Fig. 7 G).
A degree of nonuniformity existed in control fibrils (Fig.
7 G), although this was much less pronounced than that
seen in Dcn2/2 mice (Fig. 7, D–F). To quantify the
changes in mass per unit length along individual fibrils, a
simple measure of fibril uniformity was defined as the
nonuniformity index, which was equal to the range of mass
per unit length for each fibril divided by the mean massDanielson et al. Abnormal Collagen and Skin Fragility in Decorin Null Mice 737
per unit length (Fig. 7 H). Analysis of fibrils from Dcn1/1
mice showed that the nonuniformity index decreased with
increasing fibril mass per unit length (i.e., increasing fibril
diameter). Therefore, the fibrils with the most relatively
uniform shafts were the larger diameter fibrils. In contrast,
analysis of fibrils from Dcn2/2 mice showed that the in-
dex increased with increasing fibril mass per unit length.
The lumpy nature of axial mass distribution profiles of the
fibrils from the Dcn2/2 animals is consistent with a lat-
eral fusion of short fibril segments with a longer fibril. The
occurrence of lateral associations of long fibrils is also in-
dicated by the observation of twisted pairs of fibrils (Fig.
7 B). These results strongly indicate that the larger and ir-
regular skin fibrils seen in transverse sections are likely to
be a consequence of lateral fusion, producing a fibril whose
morphology changes continuously along its axial length.
Discussion
Collagen provides the principal source of mechanical
strength in connective tissues and is often implicated in
diseases where such mechanical support is defective (44).
The molecular interactions that take place among various
types of fibril-forming collagens and members of the
SLRP gene family constitute a fundamental regulatory
mechanism for the assembly of heterotypic fibrils. The re-
sults of the present investigation clearly show the develop-
mental significance of decorin as a key regulator of col-
lagen fibrillogenesis and validate previous observations
that the core protein of decorin plays a central role in reg-
ulating fibrillogenesis (10, 66, 67). Given the existence of
several members of the SLRP gene family that could con-
ceivably compensate for the lack of decorin function, the
observed phenotype was not entirely predictable. We ob-
served skin fragility and abnormal fibrillogenesis in der-
mal and tendon collagen, but not in corneal collagen, indi-
cating tissue specificity and a requirement for decorin for
proper skin and tendon development and maintenance of
normal tensile strength.
Decorin Gene Knockout Causes Abnormal Collagen 
Structure and Skin Fragility
The cross-sections of fibrils in skin and tendon showed
regular, uniform fibrils in control animals. In contrast, in
the decorin-deficient animals, the collagen fibrils were
coarser and irregular in size and shape. Furthermore, they
were often haphazardly arranged with increased inter-
fibrillar spaces. These structural changes were associated
with a reduction in collagen-bound proteoglycans in both
dermal and tendon collagen. Of note, the STEM data
showed that the fibrils in null mice were not uniform in di-
ameter but had bulges along their shafts. These data thus
explain the variability in size and shape seen in cross-sec-
tions of the skin and tendon collagen. There are two possi-
ble mechanisms to explain the formation of bulges along the
axis of individual collagen fibrils. First, the bulges (abrupt
increases in mass per unit length) could occur when early
fibrils fuse laterally onto an existing larger fibril. Our
quantitative data (Fig. 7 H) show that, as the fibril diame-
ter increases in control animals, the bulge factor decreases.
Thus, with increasing fibril diameter there is less possibil-
ity of fibril fusion. This is the reverse in the decorin-defi-
cient mice; with increasing fibril diameter, the bulge factor
increases. Interestingly, at a fixed decorin/collagen ratio,
with increasing fibril diameter, the surface area/volume ra-
tio decreases and the concentration of decorin at the fibril
surface increases. Therefore, in control mice, as the fibril
diameter increases, the concentration of decorin at the
fibril surface increases and fibril fusion is inhibited. This
Figure 5. Ultrastructural analysis of skin from the decorin-defi-
cient mice reveals abnormal collagen fibrillogenesis. (A–C) Trans-
mission electron micrographs of dermal collagen from Dcn2/2
(A and B) and Dcn1/1 ( C ) animals. Notice the presence of
larger (.200 nm) and irregular fibrils (A and B, asterisks) and the
coexistence of smaller (30–40 nm) fibrils (A, circles) in the Dcn2/2.
Note also the presence of coarser fibrils exhibiting lateral fusion
to an adjacent tapered segment (B, arrowheads). In contrast, col-
lagen from the wild-type mouse (C) showed a more compact and
uniform pattern of fibril diameter and distribution. The Dcn1/2
collagen pattern was identical to the Dcn1/1 animals (not
shown). (D and E) Distribution of collagen fibril diameter in der-
mal collagen from Dcn1/1 (D) and Dcn2/2 (E) animals. Notice
that, although the mean diameter is not significantly different be-
tween the groups, the range and distribution is quite different in
the Dcn2/2 animals. Heterozygous animals had a distribution
and an average collagen diameter (118 6 14; n 5 1,220) nearly
identical to the wild type (not shown). Bar, 0.2 mm.The Journal of Cell Biology, Volume 136, 1997 738Danielson et al. Abnormal Collagen and Skin Fragility in Decorin Null Mice 739
mechanism of restricting fibril fusion to small diameter
fibrils is lost in the decorin-deficient mice. The second pos-
sible explanation is that collagen fibrils might have a natu-
ral tendency to be irregular. Decorin, in some unknown
way, would keep the fibrils regular in outline. There is in
vitro evidence against this interpretation because fibrils
formed from purified collagen solutions tend to be fairly
uniform in cross-section (31). Furthermore, collagen fibrils
assembled in vitro from purified acid-soluble calf skin col-
lagen participate in lateral association and fusion in the
absence of decorin (unpublished observations). The most
severely affected tissue in decorin-deficient mice is skin,
which cannot withstand sudden tensile strain as its normal
counterpart does. The abnormal packing of collagen to-
gether with the nonuniformity of fiber diameter may have
a considerable influence on the biomechanics of this ten-
sile tissue. Skin fragility in these mutant animals could be
ascribed to this anomalous collagen network, which would
allow full body development and viability, but would lead
to a reduced tensile strength with potential complications
such as increased incidence of injury, infection, and scar-
ring. Biomechanical measurements using physiological stress
rates (i.e., slow stretching rates of 1 mm/s) revealed at least
a threefold reduction in tensile strength of dorsal skin
samples with a concurrent 35–40% reduction in ductility.
Of note, using similar low speed stress rates, it has been re-
cently shown that the tensile strength of rat skin correlates
with insoluble collagen and is decreased when cross-link-
ing of collagen is blocked by lathyrogen treatment (15).
This is similar to the decrease in mechanical strength de-
tected in lathyritic rat tail tendon (19).
The presence of small proteoglycans occupying the d
band of collagen fibrils in the decorin knockout animals
suggests that other members of the SLRP gene family may
bind the same sites. However, neither biglycan nor lumi-
can were upregulated at the mRNA level, thus suggesting
that there is no obligatory compensation for the lack of
decorin by at least two members of the SLRP gene family.
The absence of overt abnormalities in the cornea of
Dcn2/2 animals may be explained by the larger require-
ment for keratan sulfate in this transparent structure and
by the presence of at least five members of the SLRP gene
family, which could control more tightly the fibril diameter
necessary for transparency. Of note, b-d-xyloside, a xylose
analogue that interferes with the synthesis of chondroitin/
dermatan sulfate but not keratan sulfate proteoglycans,
Figure 6. Decorin-deficient
mice reveal abnormal col-
lagen in tail tendon and a de-
crease in collagen-associated
proteoglycans. (A) Lower
power view of cross-sectional
area of adult tail tendon col-
lagen from Dcn2/2 reveals
abnormal shape and multiple
lateral fusions. Higher
power view of Dcn2/2 ten-
dons shows bizarre, gigantic
fibrils (.660 nm in largest di-
ameter) with multiple lateral
fusions (B, arrowheads), in
contrast with the more uni-
form collagen fibrils of the
wild-type animals (C) with
an average diameter of z200
nm. Transmission electron
micrographs of longitudi-
nally sectioned collagen
fibrils from Dcn1/1 ( D )
and Dcn2/2 (E) tendon, af-
ter fixation in the presence of
0.05% cuprolinic blue and
0.3 M MgCl2, and staining
with uranyl acetate to visual-
ize the collagen binding pat-
tern. Notice that the typical,
67-nm periodicity of the type
I collagen is maintained in
the  Dcn2/2 mice (E). How-
ever, numerous d bands are
not occupied by proteogly-
can granules (E, spaces be-
tween arrowheads and un-
filled  arrowheads), in
contrast with the wild type
where nearly every d band is
occupied (D). Bar 0.2 mm.The Journal of Cell Biology, Volume 136, 1997 740
causes no alterations in fibril diameter but induces disrup-
tion of lamellar organization and fibril packing in develop-
ing avian cornea (17). These findings therefore suggest that
decorin may play a less prominent role in the regulation of
collagen fibril diameter in cornea, but is important in main-
taining the interfibrillar spacing and lamellar cohesiveness.
Decorin: A Key Regulator of Collagen Fibrillogenesis
Connective tissue interactions, including those between pro-
teoglycans and collagen, are evolutionarily conserved and
physiologically relevant. High affinity interaction of der-
matan sulfate proteoglycan with collagen was inferred three
Figure 7. Mass mapping of collagen
fibrils isolated from the skin of deco-
rin-deficient animals reveals pro-
nounced nonuniformity in the axial
mass distributions with repeated
bulges. (A–C) Typical dark-field
STEM images of isolate unstained
fibrils from mouse skin. A and B show
typical images for fibrils from a deco-
rin-deficient mouse. A shows a single
fibril with distinct bulging at two loca-
tions over 60 D-periods (1 D 5 67 nm)
length. B is consistent with two fibrils
twisted together in close contact but
not fused. C shows a typical fibril from
control skin with uniform diameter
along its length. (D–G) Axial mass dis-
tributions of single fibrils obtained by
measurements from STEM images. A
measurement of mass per unit length
was made every two D-periods along
the entire available length of each
fibril. Missing points occur where parts
of a fibril were clearly contaminated.
(D–F) Typical axial mass distribution
profiles from the decorin-deficient
sample or (G) from wild-type animals.
The decorin-deficient sample shows
pronounced mass peaks in the fibrial
axial mass distribution, which are not
found in the control. (H) Scatter plot
of the relative variation in M/L along
single fibrils against the corresponding
mean M/L. First order regression lines
are shown superimposed on each set of
data. The data from the decorin-defi-
cient samples show an overall increase
in the relative intrafibrillar variation in
M/L with increasing lateral size (Mean
M/L); this contrasts with the control
sample that shows the opposite trend.
Bar, 200 mm.Danielson et al. Abnormal Collagen and Skin Fragility in Decorin Null Mice 741
decades ago when extraction with 6 M urea or digestion
with collagenase was required for efficient isolation of this
proteoglycan from the skin (61). Moreover, it is firmly es-
tablished that (a) fibrillogenesis is a multistep assembly
process (64); (b) collagen molecules incubated in vitro at
neutral pH and physiologic temperatures aggregate and
develop into insoluble fibrils of various sizes and lengths
(31); (c) unipolar and bipolar fibrils occur in vivo (23); (d)
collagen fibrils grow from paraboloidal tips and this mech-
anism is highly regulated (23, 30); (e) the size and shape
of fibrils are enzymatically controlled by the procollagen
C-proteinase (26); and (f) this process can be modulated
by skin proteoglycans (62). When the kinetics of in vitro
fibrillogenesis were monitored by turbidimetry, it was dis-
covered that decorin from tendon (66) or cornea (45) signif-
icantly delayed collagen fibrillogenesis. The lateral assem-
bly of triple-helical collagen molecules was also delayed by
decorin resulting in thinner fibrils (8, 9, 65). During devel-
opment, the ratio of dermatan sulfate to hydroxyproline
decreases as the fibril cross-sectional areas increase (53),
an observation corroborated by the finding that fibril
growth is associated with a significant decrease in fibril-
associated decorin (8). The corollary, that thicker fibrils
are associated with less dermatan sulfate/unit weight of
collagen, can be inferred from the fact that the upper der-
mis of calf skin containing finer fibrils has twice the der-
matan sulfate/collagen ratio of deeper dermis containing
coarser fibrils (53). Of note, in human skin, the papillary
(upper) dermis expresses higher levels of decorin than
the reticular (deeper) layer (50). Collectively, these find-
ings favor a role of decorin in permitting lateral associa-
tion of fibril segments, a concept also supported by the
three-dimensional molecular model of decorin (69). Bind-
ing of decorin to collagen would interfere with further lat-
eral accretion of collagen molecules and retard/stop the
growth of fibrils. Therefore, decorin would play a pivotal
role in regulating the orderly assembly and growth of col-
lagen fibrils, which in turn would affect the tensile strength
of connective tissues. The abnormal collagen morphology
and the STEM data fully support this interpretation.
Relation of the Decorin-deficient Phenotype to 
Dermatosparaxis and Ehlers-Danlos Syndrome
Dermatosparaxis, “torn skin” syndrome, is a recessively
inherited connective tissue disorder that results from the
lack of activity of type I procollagen N-proteinase, the en-
zyme that removes the amino-terminal propeptide from
type I procollagen (36). Initially identified in cattle more
than 25 years ago, this disorder has now been reported in
sheep, cats, and dogs (5, 13, 18). Affected animals have
skin fragility, joint laxity, and often succumb prematurely
to sepsis after avulsion of portions of the skin (18). The
hallmark of the disease is the presence of abnormal col-
lagen fibrils that are thinner and haphazardly arrayed, and
often in cross-section resemble hieroglyphs. A similar syn-
drome has been now reported in three patients with skin
fragility and twisted, ribbon-like collagen fibrils (40, 41, 57).
The human syndrome, designated Ehlers-Danlos syndrome
(EDS) VIIC, differs from the EDS VIIA and VIIB insofar
as the latter two are caused by mutations of the NH2-ter-
minal propeptide of collagen a1(I) and a2(I) genes, re-
spectively (12). The mutations in EDS types VIIA and B
result in the skipping of exon 6, which contains the cleav-
age sites for the N-proteinase, thereby leading to accumu-
lation of unprocessed collagen. Intuitively, it might have
been expected that a deficiency in N-proteinase activity
and the lack of the cleavage site for the enzyme would
have given rise to the same disease. However, EDS types
VIIA and B are distinct from dermatosparaxis in that (a)
joint hypermobility, rather than skin fragility, is the princi-
pal clinical feature, and (b) ultrastructural analysis of the
dermal collagen shows rough-bordered collagen fibrils
rather than hieroglyphs (24, 68). A contribution factor to
the skin fragility in dermatosparaxis may be the steric
blocking of a factor to the gap zone of the collagen fibrils
insofar as the amino-terminal propeptide would interfere
with this region by forming a hairpin (29). In dermatospar-
actic skin, several proteoglycan filaments are not closely
bound to collagen fibrils but are floating rather freely in
the interfibrillar spaces (54). Thus, dermatosparactic ani-
mals (by blocking access to decorin) and decorin null ani-
mals (by lacking decorin) could share a common pathoge-
netic mechanism, i.e., the obstruction/deficiency of a key
regulatory molecule in collagen fibrillogenesis. Further
support for this concept is provided by the fact that the
dermatan sulfate/hydroxyproline ratio in dermatosparac-
tic skin is reduced from 4.7 to 3.6 (38). Since the surface of
the abnormal hieroglyphic collagen is two to four times
higher than that of cylindrical fibrils of normal skin, der-
matosparactic animals should also have a significant de-
crease in collagen-associated decorin.
Transgenic mice homozygous for an in-frame deletion
of exon 6 of the collagen a2(V) gene exhibit phenotypic
and ultrastructural features resembling EDS and some as-
pects of the decorin-deficient phenotype (1). The mutant
animals develop skin fragility with disorganized dermal
fibrils of variable diameter; however, the affected animals
show various degrees of kypho-lordosis and corneal ab-
normalities, not observed in the decorin null mice. Several
independent studies have now confirmed the linkage of
a1(V) collagen gene to EDS I and II (11, 37, 63). It is
known that type V collagen localizes at the periphery of
the coarser collagen fibrils, composed predominantly of
type I, and it has been proposed that the interaction be-
tween collagen types I and V regulated fibril diameter (7).
Thus, genetic defects in type V collagen could explain the
observation that collagen fibrils in skin of EDS I and II pa-
tients are larger than normal and irregular in outline.
These observations indicate that “modifiers” of collagen
fibrillogenesis, such as type V collagen and decorin, might
have profound biological consequences in vivo.
Conclusions
This study has been fruitful in establishing a functional
role for a secreted proteoglycan in maintaining the struc-
tural integrity of the cutis and perhaps tendon sheaths.
Tensile strength is certainly a major property of connec-
tive tissues, and our data demonstrate that decorin stabi-
lizes the fibrillar matrix in vivo. Decorin governs collagen
fibril growth and could influence higher order matrix as-
sembly. Understanding how changes in decorin alter the
biological properties of collagen and disrupt the finely bal-The Journal of Cell Biology, Volume 136, 1997 742
anced network of molecular interactions that govern fibril
assembly and architecture may lead to the discovery of
novel genetic disorders caused by members of the SLRP
gene family, and could potentially lead to the development
of medical strategies for their treatment. In addition to
helping to elucidate the biological role of decorin, the
decorin-deficient mouse could represent a useful animal
model to investigate matrix assembly, wound healing, and
tumorigenesis. On the basis of our animal phenotype, we
predict the existence of a human skin fragility syndrome,
to be included in the EDS category, which could be caused
by either a recessive deletion or a mutation in the collagen
binding domain of the decorin gene at the 12q23 locus.
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